Aspen Pharmacare Holdings Limited

APN

ZAE000066692

Pharmaceuticals

End-of-day quote Johannesburg S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
216.4 ^ZAR	+0.06%		-1.26%	+6.35%

Mar. 08	Aspen Pharmacare Holdings Limited Announces Board Changes	CI
Mar. 05	Aspen Pharmacare Holdings Limited Seeks Acquisitions	CI

Aspen Pharmacare : Alert and story withdrawn on Aspen and J&J in talks to produce COVID vaccine

September 02, 2021 at 02:39 am EDT

JOHANNESBURG, Sept 2 (Reuters) - An alert and story on Sept. 2 saying South Africa's Aspen Pharmacare is in talks with Johnson & Johnson relating to the manufacturing of a COVID-19 vaccine is withdrawn. The alert and story related to a December 2020 presentation and were issued in error. A substitute story will follow. STORY_NUMBER: J8N2KV00J STORY_DATE: 02/09/2021 STORY_TIME: 0615 GMT

Latest news about Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited Announces Board Changes	Mar. 07	CI
Aspen Pharmacare Holdings Limited Seeks Acquisitions	Mar. 05	CI
Transcript : Aspen Pharmacare Holdings Limited, H1 2024 Earnings Call, Mar 05, 2024	Mar. 05
Aspen Pharmacare expects FY mid-single digit earnings growth	Mar. 04	RE
Aspen Pharmacare Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Jan. 29	CI
Aspen Pharmacare Holdings Limited Announces Changes to its Board	Dec. 07	CI
Sandoz Signs Deal with Aspen Pharmacare to Sell Chinese Unit, Buy Four Anesthetic Products in Europe	Dec. 04	MT
South Africa's Aspen Pharmacare to buy Sandoz's China business	Dec. 04	RE
Transcript : Aspen Pharmacare Holdings Limited - Special Call	Nov. 29
Transcript : Aspen Pharmacare Holdings Limited - Special Call	Nov. 29
SA'S COMPETITION TRIBUNAL APPROVES DEAL WHERE ASPEN PHARMACARE T…	Nov. 14	RE
China health sector sees better sentiment from anti-graft drive - execs	Nov. 09	RE
Inflation Data, Central Bank Meeting Focus Send South African Stocks Lower	23-09-19	MT
Novo Nordisk Announces Partnership to Establish Insulin Production in South Africa	23-09-19	DJ
South African Stocks in the Green Ahead of US Fed's Rate Meeting	23-09-19	MT
Novo Nordisk, Aspen Pharmacare Sign Insulin Production Deal for Africa	23-09-19	MT
Novo Nordisk contracts South Africa's Aspen to produce insulin for African nations	23-09-19	RE
Aspen Pharmacare Holdings Limited and Aspen SA Operations Ltd Conclude an Agreement with Novo Nordisk A/S	23-09-19	CI
Aspen Pharmacare Subsidiary Wins Contract Manufacturing Agreement	23-09-06	MT
Transcript : Aspen Pharmacare Holdings Limited, 2023 Earnings Call, Aug 31, 2023	23-08-31
South African Stocks Rise Amid US Private Sector Employment Data	23-08-30	MT
Aspen Pharmacare Logs Lower FY23 Attributable Profit; Revenue Up	23-08-30	MT
South African drugmaker Aspen posts 4% drop in annual profit	23-08-30	RE
Aspen Pharmacare Secures Rights to Distribute, Promote Eli Lilly Products in Africa	23-08-30	MT
Aspen Pharmacare Holdings Limited Declares Gross Dividend, Payable on 26 September 2023	23-08-30	CI

Chart Aspen Pharmacare Holdings Limited

Duration

Period

More charts

Company Profile

Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (71.6%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (28.4%): infant nutrition products and consumer products. At the end of June 2022, the group had 16 production sites worldwide.

Sector

Pharmaceuticals

Calendar

2024-09-02 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Aspen Pharmacare Holdings Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

216.4 ZAR

Average target price

232 ZAR

Spread / Average Target

+7.21%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ASPEN PHARMACARE HOLDINGS LIMITED	+6.35%	5.06B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.89B
SANDOZ GROUP AG	+13.75%	14.45B
CIPLA LIMITED	+13.09%	13.63B
ZYDUS LIFESCIENCES LIMITED	+37.76%	11.49B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.85B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-5.36%	4.66B
RICHTER GEDEON VEGYÉSZETI GYÁR NYILVÁNOSAN MUKÖDO RT.	+2.40%	4.53B

Generic Pharmaceuticals

Aspen Pharmacare Holdings Limited

Equities

APN

ZAE000066692

Pharmaceuticals

Aspen Pharmacare : Alert and story withdrawn on Aspen and J&J in talks to produce COVID vaccine

EPS Revisions